acetylsalicylic acid tab 325mg bp tablet
wes pak products ltd. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates
acetylsalicylic acid 325mg tablets usp
prodemdis enr. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates
acetylsalicylic acid 325mg tablets usp
cellchem pharmaceuticals inc. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates
acetylsalicylic acid extra strength 500mg tablets usp
cellchem pharmaceuticals inc. - acetylsalicylic acid - tablet - 500mg - acetylsalicylic acid 500mg - salicylates
acetylsalicylic acid stomach protection 325mg tablets
cellchem pharmaceuticals inc. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates
acetylsalicylic acid extra strength stomach protection 500mg caplets tablet
cellchem pharmaceuticals inc. - acetylsalicylic acid - tablet - 500mg - acetylsalicylic acid 500mg - salicylates
acetylsalicylic acid, caffeine and 8 mg codeine phosphate tablet
cellchem pharmaceuticals inc. - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 375mg; 15mg; 8mg - acetylsalicylic acid 375mg; caffeine 15mg; codeine phosphate 8mg - opiate agonists
acetylsalicylic acid, caffeine & 8 mg codeine phosphate tablets
jamp pharma corporation - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 375mg; 15mg; 8mg - acetylsalicylic acid 375mg; caffeine 15mg; codeine phosphate 8mg - opiate agonists
aspirin cardio
bayer israel ltd - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
cartia
padagis israel agencies ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.